Elicit: Efficacy of SGLT Activators on Water Absorption (public)

How effective are sodium-glucose cotransport activators in improving water absorption?

Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.

Abstract

Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‑alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.

Methods

We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.

Results

Characteristics of Included Studies

Study	Study Design	Clinical Condition	Intervention Type	Primary Outcome Measure	Full text retrieved
Wapnir et al., 1988	Animal experimental study	Osmotic diarrhea (rats)	L-alanine, protein hydrolysate in oral hydration solution	Water and sodium absorption	No
Rongione et al., 2001	Animal experimental; in vivo physiological	Normal dogs	Epidermal Growth Factor (EGF), Transforming Growth Factor (TGF)	Sodium, chloride, water, glucose absorption	No
Grahammer et al., 2006	Animal experimental; in vivo physiological	Normal and dexamethasone-treated mice	Dexamethasone	SGLT1 / NHE3 activity, sodium absorption	No
Aguero et al., 1990	Animal experimental; in vivo physiological	Normal and diarrheic Wistar rats	Glutamine in World Health Organization Oral Rehydration Solution	Sodium and water absorption	No
Wapnir et al., “Enhancement by Alanine”	Animal experimental; in vivo physiological	Chronic diarrhea (rats)	L-alanine, protein hydrolysate in oral hydration solution	Water and sodium absorption	No
...	...	...	...	...	...

Water Absorption Outcomes

Study	Activator Type	Water Absorption Effect	Effect Size	Statistical Significance
Wapnir et al., 1988	L-alanine, protein hydrolysate	Increased water absorption	"Very significant increase"	No mention found
Rongione et al., 2001	EGF, TGF	Increased water absorption	Not quantified	Significant vs. mixed meal
Grahammer et al., 2006	Dexamethasone	No mention found	N/A	N/A
...	...	...	...	...

Sodium Absorption Outcomes

Study	Activator Type	Sodium Absorption Effect	Effect Size	Statistical Significance
Wapnir et al., 1988	L-alanine, protein hydrolysate	Increased sodium absorption	"Very significant increase"	No mention found
Rongione et al., 2001	EGF, TGF	Increased sodium absorption	Not quantified	Significant
...	...	...	...	...

Context-Dependent Effects and Generalizability

Animal versus human studies: Most evidence is from animal models, which limits direct translation to human clinical settings. Human studies reported beneficial effects in both health and disease.
Disease models: The magnitude of effect was often greater in diarrheal or secretory models than in healthy controls.
Limitations of the evidence: Many studies lacked detailed reporting of sample size, sex, or age, and some were only available as abstracts.